Berodual Inhalation Solution

Berodual Inhalation Solution is a solution with Ipratropium Bromide declared as its active content. It is supplied in a pack size of 20ml.

This is a non-prescription product and can be purchased without a prescription. Only product, safety and handling details are published on this page.

An online consultation with a DoctorOnCall doctor or pharmacist is available for this product, and a registered pharmacist reviews each order before dispatch to Malaysia or Singapore. Follow the directions on the label and on the leaflet inside the pack.

Berodual Inhalation Solution must only be used with a nebulizer device as directed by the prescribing doctor or pharmacist. The prescribed dose is measured out, diluted with sterile saline solution if instructed, and placed into the nebulizer chamber, then inhaled through a mouthpiece or face mask over several minutes until the chamber is empty. It should not be swallowed, injected, or used in any device other than a nebulizer, and the equipment should be cleaned after each use to reduce the risk of contamination.

Dosage of Berodual Inhalation Solution is individualised by the prescribing doctor based on the patient’s age, severity of symptoms, and response to treatment, and must never be adjusted without medical advice. Typical adult regimens involve a measured number of drops diluted in saline and nebulized several times a day, with lower doses generally used in children under medical supervision; patients should follow the exact schedule given on their prescription label and seek medical review if symptoms are not adequately controlled.

Berodual Inhalation Solution should be used within the shelf-life period printed on the manufacturer’s packaging when stored correctly and unopened. Once a multidose bottle has been opened, it should be used within the timeframe advised by the pharmacist, and any solution that appears discoloured or is past its expiry date should not be used.

Store Berodual Inhalation Solution below 25°C, away from direct sunlight and excessive heat, and keep the bottle tightly closed between uses. Keep it out of reach and sight of children, and do not store it in the bathroom or near a sink where humidity and temperature fluctuate.

• Known hypersensitivity to ipratropium bromide, fenoterol, atropine-like compounds, or any excipient in the solution
• Hypertrophic obstructive cardiomyopathy
• Tachyarrhythmia (fast, irregular heart rhythms)
• Use with caution in patients with a history of glaucoma, prostatic hyperplasia, or bladder outlet obstruction
• Use with caution in patients with cardiovascular disease, including coronary artery disease and uncontrolled hypertension

• Other beta-adrenergic bronchodilators may increase the risk of side effects when used together
• Beta-blocker medicines may reduce the effectiveness of Berodual and should be reviewed by a doctor
• Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants may increase cardiovascular side effects
• Xanthine derivatives such as theophylline may increase the risk of low potassium levels when combined
• Corticosteroids and diuretics used concurrently may increase the risk of low blood potassium
• Inform the doctor of all prescription, over-the-counter, and herbal products currently being used

• Only use Berodual Inhalation Solution with a nebulizer device as prescribed
• Attend follow-up appointments so the doctor can monitor response and adjust treatment if needed
• Rinse the mouth after nebulizing to reduce dryness or irritation
• Seek urgent medical attention if breathing difficulty worsens despite treatment
• Do not exceed the prescribed frequency or dose without consulting the prescribing doctor
• Keep a record of symptom triggers to discuss at follow-up visits

Because Berodual Inhalation Solution combines two bronchodilator mechanisms, it is generally reserved for patients whose airway symptoms are not fully controlled on a single agent, and ongoing use should be reviewed periodically by the prescribing doctor to confirm it remains the right treatment. Patients with underlying heart conditions, thyroid disorders, or diabetes should mention these to their doctor, as the medicine may affect heart rate and blood sugar control in some individuals.